301520SZSE
🚨 Material Event

Announcement on the Progress of Acquiring 75.52% Equity of Anhui Saidesheng Pharmaceutical Technology Co., Ltd. and Completion of Industrial and Commercial Registration Change

Wanbang Pharmaceutical Co., Ltd.··2 pages

✨ AI Summary

Anhui Wanbang Pharmaceutical Technology Co., Ltd. announces the progress of its acquisition of 75.52% equity in Anhui Saidesheng Pharmaceutical Technology Co., Ltd. The company has completed the industrial and commercial registration change for the acquisition, with Saidesheng becoming a holding subsidiary. The transaction involved RMB 30,207.76 million.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 301520 Securities Abbreviation: Wanbang Pharmaceutical Announcement No.: 2026-022

Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Announcement on the Progress of Acquiring 75.52% Equity of Anhui Saidesheng Pharmaceutical Technology Co., Ltd. and Completion of Industrial and Commercial Registration Change

The Company and the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.

I. Transaction Overview

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.